The biotech firm reported earnings above expectations but missed revenue estimates for the quarter by $3.7M.
Immunocore reported a GAAP EPS of $0.25, surpassing estimates by $0.47. Revenue reached $106.68M, missing expectations by $3.7M.
Analysts had anticipated lower earnings but higher revenue for the quarter. The company’s prior quarter performance and industry trends set the context for these results.
Market reaction to the mixed results remains unclear as of publication.